Different studies in animal models and cancer patients demonstrated that high levels of interleukin 6 (IL-6) correlate with muscle wasting, inhibition of protein synthesis, promotion of protein degradation and autophagy in myotubes (White et al., 2011; Pettersen et al., 2017). Here, IL6 is linked to cancer.